bupivacaine has been researched along with Spinal Cord Neoplasms in 5 studies
Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.
Spinal Cord Neoplasms: Benign and malignant neoplasms which occur within the substance of the spinal cord (intramedullary neoplasms) or in the space between the dura and spinal cord (intradural extramedullary neoplasms). The majority of intramedullary spinal tumors are primary CNS neoplasms including ASTROCYTOMA; EPENDYMOMA; and LIPOMA. Intramedullary neoplasms are often associated with SYRINGOMYELIA. The most frequent histologic types of intradural-extramedullary tumors are MENINGIOMA and NEUROFIBROMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ueshima, H | 1 |
| Otake, H | 1 |
| Holmfred, A | 1 |
| Wadhwa, RK | 1 |
| Shaya, MR | 1 |
| Nanda, A | 1 |
| Lema, MJ | 1 |
| Shady, JA | 1 |
| Zoll, JG | 1 |
| West, CR | 1 |
| Berde, CB | 1 |
| Sethna, NF | 1 |
| Conrad, LS | 1 |
| Hershenson, MB | 1 |
| Shillito, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effectiveness of Ultrasound-guided Erector Spinae Plane Block for Postoperative Pain Control in Hip Replacement Surgeries[NCT04003909] | 30 participants (Actual) | Interventional | 2019-07-05 | Completed | |||
| Randomized Clinical Trial of Erector Spinae Plane (ESP) Versus Paravertebral Nerve (PVB) Blockade for Video Assisted Thoracoscopic Surgery (VATS)[NCT03758261] | Phase 4 | 35 participants (Actual) | Interventional | 2019-03-11 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Amount achieved on incentive spirometer device (mL). Higher level indicates better respiratory effort (NCT03758261)
Timeframe: 1 day post catheter removal
| Intervention | milliliter (mL) (Mean) |
|---|---|
| Erector Spinae Nerve Block | 1221.15 |
| Paravertebral Nerve Block | 1187.50 |
Averaged total Narcotic consumption measured in Oral Morphine Equivalence (OME) (NCT03758261)
Timeframe: 0-120 hours post-operative
| Intervention | Average of OME (Mean) |
|---|---|
| Erector Spinae Nerve Block | 187.36 |
| Paravertebral Nerve Block | 164.7 |
Length of hospital stay post-surgery (NCT03758261)
Timeframe: Up to 2 weeks on average
| Intervention | hours (Mean) |
|---|---|
| Erector Spinae Nerve Block | 101.96 |
| Paravertebral Nerve Block | 96.30 |
Visual analog scale. Scale is from 0 to 10 numerical pain rating scale. 0 indicates no pain. 10 indicates maximum level of pain. Higher scores indicate worse pain level. Pain score will be a single number from 0 to 10. (NCT03758261)
Timeframe: 1 day post catheter removal
| Intervention | score on a scale (Mean) |
|---|---|
| Erector Spinae Nerve Block | 5.98 |
| Paravertebral Nerve Block | 5.16 |
Participant count for patients who experienced adverse events with nerve block catheter placement which includes pneumothorax, infections, bleeding, local anesthetic toxicity. (NCT03758261)
Timeframe: 1 day post catheter removal
| Intervention | Participants (Count of Participants) |
|---|---|
| Erector Spinae Nerve Block | 0 |
| Paravertebral Nerve Block | 0 |
How long catheter remains providing pain relief (NCT03758261)
Timeframe: 6 days
| Intervention | hours (Mean) |
|---|---|
| Erector Spinae Nerve Block | 21.99 |
| Paravertebral Nerve Block | 21.94 |
Morphine equivalents (total OME) (NCT03758261)
Timeframe: 1 day post catheter removal
| Intervention | mg morphine equivalent (MME) (Mean) |
|---|---|
| Erector Spinae Nerve Block | 187.36 |
| Paravertebral Nerve Block | 164.70 |
5 other studies available for bupivacaine and Spinal Cord Neoplasms
| Article | Year |
|---|---|
RETRACTED: Clinical experiences of ultrasound-guided erector spinae plane block for thoracic vertebra surgery.
Topics: Aged; Aged, 80 and over; Anesthesia, General; Anesthesia, Intravenous; Anesthetics, Intravenous; Ane | 2017 |
RETRACTED: Clinical experiences of ultrasound-guided erector spinae plane block for thoracic vertebra surgery.
Topics: Aged; Aged, 80 and over; Anesthesia, General; Anesthesia, Intravenous; Anesthetics, Intravenous; Ane | 2017 |
RETRACTED: Clinical experiences of ultrasound-guided erector spinae plane block for thoracic vertebra surgery.
Topics: Aged; Aged, 80 and over; Anesthesia, General; Anesthesia, Intravenous; Anesthetics, Intravenous; Ane | 2017 |
RETRACTED: Clinical experiences of ultrasound-guided erector spinae plane block for thoracic vertebra surgery.
Topics: Aged; Aged, 80 and over; Anesthesia, General; Anesthesia, Intravenous; Anesthetics, Intravenous; Ane | 2017 |
Failed intrathecal analgesia following severe, terminal cancer pain.
Topics: Amines; Analgesics; Anesthetics, Local; Back Pain; Bupivacaine; Catheterization; Clonidine; Cyclohex | 2004 |
Spinal cord compression in a patient with a pain pump for failed back syndrome: a chalk-like precipitate mimicking a spinal cord neoplasm: case report.
Topics: Aged; Back Pain; Bupivacaine; Calcium Carbonate; Diagnosis, Differential; Female; Humans; Infusion P | 2006 |
Management of intractable back pain from caudal ependymoma with spinal methylprednisolone, bupivacaine and morphine.
Topics: Adult; Bupivacaine; Cauda Equina; Drug Combinations; Ependymoma; Female; Humans; Injections, Spinal; | 1992 |
Subarachnoid bupivacaine analgesia for seven months for a patient with a spinal cord tumor.
Topics: Adult; Analgesia; Astrocytoma; Bupivacaine; Female; Humans; Pain, Intractable; Spinal Cord Neoplasms | 1990 |